Atrionix, Inc.
| Atrionix is dedicated to the development and manufacture of leading edge products for the diagnosis and treatment of atrial fibrillation. Atrial fibrillation is the most prevalent cardiac arrhythmia, affecting approximately five million people worldwide. The company has developed several patented medical devices which will eliminate the need for surgical intervention in the treatment of atrial fibrillation. These minimally invasive devices will reduce patient morbidity and recovery time compared to surgical techniques. |
|